iRhythm Is ‘Encouraged’ By Recent Reimbursement Discussions With Novitas

The company provided another update on its ongoing efforts to secure adequate Medicare reimbursement for long-term continuous cardiac monitoring.

Handshake - Image ID: BNWW16
• Source: Alamy

Cardiac monitoring company iRhythm Technologies is not giving up on providing its Zio XT 14-day cardiac monitoring system to Medicare beneficiaries and will continue to provide Zio XT to these users while it seeks higher reimbursement rates for its device and services.

Medicare reimbursement for Zio XT depends almost entirely on Novitas, because iRhythm’s service center is in Texas and Novitas is...

More from Policy & Regulation

More from Medtech Insight